Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Feb;31(2):178–188.

Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma.

P L Haslam, A Lukoszek, J A Merchant, M Turner-Warwick
PMCID: PMC1541206  PMID: 648028

Abstract

Quantitative impairment of lymphocyte responses to phytohaemagglutinin (PHA) has been demonstrated in six (21%) out of twenty-eight patients with asbestos-associated pulmonary fibrosis, in comparison with a group of unexposed normal controls. The impairment tended to occur in patients with fairly severe fibrosis, comparatively short duration of exposure to asbestos dust and with increases in serum immunoglobulin levels. One patient with asbestosis and an associated bronchial carcinoma also had depressed lymphocyte responses to PHA. These findings suggest a relationship between defective T-lymphocyte function and the fibrotic response in asbestosis. Whether it is also linked with the development of lung cancer, occurring either before or at a pre-clinical stage of tumour growth, and is of value in identifying patients especially at risk should now be explored in longitudinal studies. However, eight out of ten patients with asbestos-associated pleural mesothelioma and without lung fibrosis showed no evidence of impaired cellular immunity, either by in vitro testing with PHA or by vivo delayed hypersensitivity skin testing, indicating that impaired T-lymphocyte function is unlikely to be a common finding in all types of asbestos-associated malignancy.

Full text

PDF
178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brugarolas A., Han T., Takita H., Minowada J. Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count. N Y State J Med. 1973 Mar 15;73(6):747–750. [PubMed] [Google Scholar]
  2. Dellon A. L., Potvin C., Chretien P. B. Thymus-dependent lymphocyte levels in bronchogenic carcinoma: correlations with histology, clinical stage, and clinical course after surgical treatment. Cancer. 1975 Mar;35(3):687–694. doi: 10.1002/1097-0142(197503)35:3<687::aid-cncr2820350322>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  3. Fitzgerald M. G. The establishment of a normal human population dose-response curve for lymphocytes cultured with PHA (phytohaemagglutinin). Clin Exp Immunol. 1971 Mar;8(3):421–425. [PMC free article] [PubMed] [Google Scholar]
  4. Glasgow A. H., Nimberg R. B., Menzoian J. O., Saporoschetz I., Cooperband S. R., Schmid K., Mannick J. A. Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer. N Engl J Med. 1974 Dec 12;291(24):1263–1267. doi: 10.1056/NEJM197412122912401. [DOI] [PubMed] [Google Scholar]
  5. Han T., Pauly J. Simplified whole blood method for evaluating in vitro lymphocyte reactivity of laboratory animals. Clin Exp Immunol. 1972 May;11(1):137–142. [PMC free article] [PubMed] [Google Scholar]
  6. Haslam P., Lukoszek A., Longbottom J. L., Turner-Warwick M. Lymphocyte sensitization to Aspergillus fumigatus antigens in pulmonary diseases in man. Clin Allergy. 1976 May;6(3):277–291. doi: 10.1111/j.1365-2222.1976.tb01908.x. [DOI] [PubMed] [Google Scholar]
  7. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  8. Holmes E. C., Golub S. H. Immunologic defects in lung cancer patients. J Thorac Cardiovasc Surg. 1976 Feb;71(2):161–168. [PubMed] [Google Scholar]
  9. Hosking C. S., Fitzgerald M. G., Simons M. J. Quantified deficiency of lymphocyte response to phytohaemagglutinin in immune deficiency diseases. Clin Exp Immunol. 1971 Oct;9(4):467–476. [PMC free article] [PubMed] [Google Scholar]
  10. Janossy G., Greaves M. F. Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol. 1971 Oct;9(4):483–498. [PMC free article] [PubMed] [Google Scholar]
  11. Junge U., Hoekstra J., Wolfe L., Deinhardt F. Microtechnique for quantitative evaluation of in vitro lymphocyte transformation. Clin Exp Immunol. 1970 Sep;7(3):431–437. [PMC free article] [PubMed] [Google Scholar]
  12. Kagan E., Solomon A., Cochrane J. C., Beissner E. I., Gluckman J., Rocks P. H., Webster I. Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity. Clin Exp Immunol. 1977 May;28(2):261–267. [PMC free article] [PubMed] [Google Scholar]
  13. Kagan E., Solomon A., Cochrane J. C., Kuba P., Rocks P. H., Webster I. Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity. Clin Exp Immunol. 1977 May;28(2):268–275. [PMC free article] [PubMed] [Google Scholar]
  14. Kang K. Y., Yagura T., Sera Y., Yokoyama K., Yamamura Y. Antinuclear factor in pneumoconioses and idiopathic pulmonary fibrosis. Med J Osaka Univ. 1973 Mar;23(4):249–256. [PubMed] [Google Scholar]
  15. Kang K., Sera Y., Okochi T., Yamamura Y. Letter: T lymphocytes in abestosis. N Engl J Med. 1974 Oct 3;291(14):735–736. doi: 10.1056/NEJM197410032911414. [DOI] [PubMed] [Google Scholar]
  16. Krant M. J., Manskopf G., Brandrup C. S., Madoff M. A. Immunologic alterations in bronchogenic cancer. Sequential study. Cancer. 1968 Apr;21(4):623–631. doi: 10.1002/1097-0142(196804)21:4<623::aid-cncr2820210414>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  17. Lange A., Smolik R., Zatoński W., Szymańska J. Autoantibodies and serum immunoglobulin levels in asbestos workers. Int Arch Arbeitsmed. 1974 Jan 31;32(4):313–325. doi: 10.1007/BF02178970. [DOI] [PubMed] [Google Scholar]
  18. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  19. McDevitt H. O., Bodmer W. F. HL-A, immune-response genes, and disease. Lancet. 1974 Jun 22;1(7869):1269–1275. doi: 10.1016/s0140-6736(74)90021-x. [DOI] [PubMed] [Google Scholar]
  20. Merchant J. A., Klouda P. T., Soutar C. A., Parkes W. R., Lawler S. D., Turner-Warwick M. The HL-A system in asbestos workers. Br Med J. 1975 Jan 25;1(5951):189–191. doi: 10.1136/bmj.1.5951.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. PLOTZ C. M., SINGER J. M. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med. 1956 Dec;21(6):888–892. [PubMed] [Google Scholar]
  22. Paty D. W., Hughes D. Lymphocyte transformation using whole blood cultures: an analysis of responses. J Immunol Methods. 1972 Nov;2(1):99–114. doi: 10.1016/0022-1759(72)90022-1. [DOI] [PubMed] [Google Scholar]
  23. Penhale W. J., Farmer A., Maccuish A. C., Irvine W. J. A rapid micro-method for the phytohaemagglutinin-induced human lymphocyte transformation test. Clin Exp Immunol. 1974 Sep;18(1):155–167. [PMC free article] [PubMed] [Google Scholar]
  24. Silverman N. A., Potvin C., Alexander J. C., Jr, Chretien P. B. In vitro lymphocyte reactivity and T-cell levels in chronic cigarette smokers. Clin Exp Immunol. 1975 Nov;22(2):285–292. [PMC free article] [PubMed] [Google Scholar]
  25. WAGNER J. C., SLEGGS C. A., MARCHAND P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960 Oct;17:260–271. doi: 10.1136/oem.17.4.260. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES